معرفی
Gaia Fumagalli is a researcher at the Department of Chemistry, University of Milan, specializing in pharmaceutical sciences with a focus on nanoparticle-based drug delivery systems for cancer treatment. Her work bridges chemistry, nanotechnology, and oncology, with an emphasis on developing innovative approaches to overcome cancer resistance.
Dr. Fumagalli's research interests center on nanomedicine and drug delivery systems, particularly self-assembled nanoparticles using natural products and drug conjugates. Her work explores the structural and chemical properties of compounds like dehydroroyleanone, ecdysteroids, and triazole rings as building blocks for therapeutic applications. She investigates how these formulations can improve drug efficacy, particularly in challenging areas like cancer stem cell targeting and multidrug resistance.
Analysis of her publication record from 2015-2022 reveals a consistent focus on anticancer drug delivery with increasing sophistication in nanoparticle design. Her work demonstrates progression from basic conjugate chemistry to advanced imaging techniques for tracking cellular internalization. The research spans multiple disciplines including pharmaceutical science, organic chemistry, and cancer biology, with particular emphasis on natural product derivatives and their therapeutic applications.
Dr. Fumagalli maintains an active collaborative network, frequently working with researchers including D. Passarella, M.S. Christodoulou, and E. Colombo. Her geographical research footprint shows significant international collaboration across Europe, North America, and Asia, reflecting the global nature of her scientific contributions to nanomedicine.
Her laboratory work involves developing and characterizing self-assembled nanoparticle systems, with particular expertise in fluorescence imaging techniques for tracking drug delivery. Current research directions appear focused on overcoming cancer resistance mechanisms through innovative nanoparticle formulations that combine multiple therapeutic agents.
